Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nov 9th press release available under sec forms 8k
and under array news (yes, i did not see it at first, but then again, i did not go to harvard or yale)
COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress
- Binimetinib plus encorafenib meets primary endpoint with statistically significant advantage on median PFS of 14.9 months versus 7.3 months for vemurafenib monotherapy -
- Additional PFS, ORR and durability data support primary endpoint result -
- Detailed safety and drug exposure data presented; combination of binimetinib plus encorafenib demonstrates a favorable tolerability profile -
- See more at: http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2221003#sthash.F0F7dqVL.dpuf
pps is responding well i must say,
i hope we hear a public update at 1pm or so in response to data shown at the conference.
maybe they jumped the gun by posting the results 4 days prior to when they could expand upon any data points or questions?
thanks ddi.
not enough tweets?
what did it today.
because of too many tweets???
because it is a small p2?
they have that late breaking abstract thing at the SMR, we all ready have some of the info, but i think we will get more. plus it is followed by an investor's q&a at 1pm.
i have no idea what to make of today.
i don't think i learned anything either.
maybe the presentations will help.
reminder: wed. nov 9.
that is tomorrow!
SMR. 10am. late-breaking abstract. oral presentation. columbus. 15 min.
followed by
investor reception. 1pm. encore presentation. columbus. live webcast. public welcome to participate. 2 hr.
i believe we will get the detail on columbus
it will be a miracle if we ever make it to $10.
if news so good.why only $1.73? why not $10.73?
the harvards are saying this is only worth 6 and 4 pennies.
what say you princetonians? or are the wedgies too much for yee...
it appears as if the princetons haven't got it in them, i dare say.
if they can't get the muster behind the ol' ticker tape, then what shall we do.
"stop giving me a wedgie"
"stop giving me a wedgie"
i hear this at all of the trivial pursuit championships at princeton. it surely must be their motto.
maybe if i say it more emphatically,
"stop giving me a wedgie!"
"STOP giving me a WedgIe!!"
no. the price is now at $6.03.
no wonder princetonians get wedgies, they haven't got the moxy.
oh no, it appears as if i offended someone from princeton as the price dropped to $6.05.
oh dear.
"stop giving me a wedgie" "stop giving me a wedgie"
that'll rally the troops.
$6.08 is all right, but the yale-ies are having a number on you harvards.
maybe $6.10 would be decent if it were not obscenely low.
what we need is the ol' princeton battle cry to get us over $7.
what is the princeton battle cry you say?
it is "stop giving me a wedgie" "stop giving me a wedgie"!!!
i just tweeted him.
nope, i think i deleted it.
i don't know.
tweeting is very complicated.
i may need some help with the tweet.
should i tweet him?
i think he is best accessible via his tweets
dear sids,
did you say that on nov 9th they are doing some stuff?
that is ca-ray-zeees.
nov 9th
nov 9th
nov 9th
you call that volume? who are you kidding.
i've got more volume in me belly.
give me volume.
i'll show you volume.
come on. where is your old princeton spirit.
that's right. come on.
we can do this thang.
the ask is only $6.04??? come on players. you can do better than that. where is the old princeton spirit? is this all ya got?
as long as people live, that is all that matters.
reminder: wed. nov 9.
three days away!!!!
SMR. 10am. late-breaking abstract. oral presentation. columbus. 15 min.
followed by
investor reception. 1pm. encore presentation. columbus. live webcast. public welcome to participate. 2 hr.
meh.
is this opinion or conjecture
i get confused between the two
speculation.
in what capacity?
speculation.
if it matters, then who cares.
it will be a side note.
don't you want to hear about the side notes?
maybe they mean something.
for us, despite unwanted perceptions,
all that matters is data.
thank g++dness for that.
it pushes through all of the stuff
that i see on this thing.
sincerely,
Francious "vichy squab" Underbuckle
maybe this will be brought up at the thing?
does dr pierce know that pd1's go on the cell and not in the cell? this ep thing doesn't make sense now that the esteemed dr. lowenstein has raised the red alert.
why would one want to electroporate PD1 inhibitors? EP is a process for getting DNA and genes INTO cells. PD1 is a receptor ON cells, the ligands PD L1 and PD l2 are expressed on the surface of cells. Not sure what the rationale is here
Really???? Can you cite literature references that support that.
i like the tea leaves at this point,
but could the vol spike have been caused by the jbem followers, or one of those twitter "gurus" that has a legion that buys in prior to any announcement?
thanks lasers. i did look through the management board but must have blanked out on his name or not scrolled far enough, it was late.
old news, not even news as it was previously examined, but the amendment listed dr pierce as having left the company in june 2016 with no severance pay, however retained as a consultant with an income of $30k/mo; so i am now assuming that the lack of a severance pay was not due to some bad event but renegotiated to the $30k/mo consultation fee. it was late in the night and i thought it strange considering that 5mo later we are at this point with a reveal on the trial. meh.
where is dr. pierce now? it has been a few months.
meh.
i am sure they have their reasons.
this is the only part that stands out (red):
>The Plan Administrator may also provide for the cashing out of outstanding and vested options and stock appreciation rights based on the based upon the per-share consideration being paid in connection with such change in control, less the applicable exercise price or base amount. The Amended Plan also modifies the definitions of “Change in Control” and “Corporate Transactions.” <
based on the based upon what is inked out,
there is no money for a proof reader who specializes in legal-ese;
i hope that does not effect their stock appreciation rights in the event of a "change in control" as modified in the amended plan.
meh.
reminder:
wed. nov 9.
a week and several days away.
SMR. 10am. late-breaking abstract. oral presentation. columbus. 15 min.
followed by
investor reception. 1pm. encore presentation. columbus. live webcast. public welcome to participate. 2 hr.
meh.
is that the recipe? 'cause i have another stock with an oral, late-breaking abstract presentation at SMR for braf melanoma. maybe they just like oral?